Copyright
©The Author(s) 2015.
World J Clin Cases. Sep 16, 2015; 3(9): 774-778
Published online Sep 16, 2015. doi: 10.12998/wjcc.v3.i9.774
Published online Sep 16, 2015. doi: 10.12998/wjcc.v3.i9.774
Grade | Lobular architecture preservation | Mitotic index | Nuclear polymorphism | Fibrillary matrix | Rosettes | Necrosis |
I | + | Zero | None | Prominent | HW rosettes | None |
II | + | Low | Low | Present | HW rosettes | None |
III | +/- | Moderate | Moderate | Low | FW rosettes | Rare |
IV | +/- | High | High | Absent | None | Frequent |
Stage A: Tumour limited to the nasal fossa |
Stage B: Tumour extension into the paranasal sinuses |
Stage C: Tumour extension beyond the paranasal sinuses and nasal cavity |
Stage D: Distant metastasis |
T1 | Tumour involving the nasal cavity and/or paranasal sinuses (excluding sphenoid), sparing the most superior ethmoidal cells |
T2 | Tumour involving the nasal cavity and/or paranasal sinuses (including the sphenoid) with extension to or erosion of the cribriform plate |
T3 | Tumour extending into the orbit or protruding into the anterior cranial fossa, without dural invasion |
T4 | Tumour involving the brain |
N0 | No cervical lymph-node metastasis |
N1 | Any form of cervical lymph-node metastasis |
M0 | No metastases |
M1 | Distant metastasis |
- Citation: Kumar R. Esthesioneuroblastoma: Multimodal management and review of literature. World J Clin Cases 2015; 3(9): 774-778
- URL: https://www.wjgnet.com/2307-8960/full/v3/i9/774.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v3.i9.774